Janus Henderson Group PLC Gilead Sciences, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,131,517 shares of GILD stock, worth $134 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,131,517

Previous 728,417 55.34%

Holding current value

$134 Million

Previous $81.6 Million 53.7%

% of portfolio

0.06%

Previous 0.05%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$96.91 - $113.0 $39.1 Million - $45.6 Million	403,100 Added 55.34%	1,131,517 $125 Million
Q1 2025 May 15, 2025	SELL	$89.14 - $117.41 $50.6 Million - $66.6 Million	-567,660 Reduced 43.8%	728,417 $81.6 Million
Q4 2024 Feb 14, 2025	SELL	$83.95 - $97.9 $39.1 Million - $45.6 Million	-465,484 Reduced 26.42%	1,296,077 $120 Million
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $6.53 Million - $8.24 Million	98,067 Added 5.9%	1,761,561 $148 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $3.17 Million - $3.66 Million	-50,249 Reduced 2.93%	1,663,494 $114 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $4.02 Million - $4.9 Million	-56,157 Reduced 3.17%	1,713,743 $126 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $8.7 Million - $9.87 Million	-118,742 Reduced 6.29%	1,769,900 $143 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $2.14 Million - $2.33 Million	-28,925 Reduced 1.51%	1,888,642 $142 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $23.6 Million - $26.9 Million	310,811 Added 19.34%	1,917,567 $148 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $33.3 Million - $38 Million	-431,194 Reduced 21.16%	1,606,756 $133 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $5.88 Million - $8.44 Million	-94,370 Reduced 4.43%	2,037,950 $175 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $46.7 Million - $53.3 Million	-783,593 Reduced 26.87%	2,132,320 $132 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $138 Million - $156 Million	-2,399,373 Reduced 45.14%	2,915,913 $180 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.31 Million - $1.64 Million	-22,544 Reduced 0.42%	5,315,286 $316 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $8.6 Million - $9.76 Million	-132,509 Reduced 2.42%	5,337,830 $388 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $15.8 Million - $17.1 Million	233,792 Added 4.46%	5,470,339 $382 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $49.2 Million - $53.7 Million	775,016 Added 17.37%	5,236,547 $361 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $30.6 Million - $34.9 Million	-509,988 Reduced 10.26%	4,461,531 $288 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $17.4 Million - $19.8 Million	-307,322 Reduced 5.82%	4,971,519 $290 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $35.8 Million - $45 Million	-576,816 Reduced 9.85%	5,278,841 $334 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $4.62 Million - $5.37 Million	63,922 Added 1.1%	5,855,657 $451 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $51.6 Million - $66.1 Million	-823,733 Reduced 12.45%	5,791,735 $433 Million
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $85.8 Million - $94.4 Million	1,392,639 Added 26.66%	6,615,468 $430 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $48 Million - $52.9 Million	767,158 Added 17.22%	5,222,829 $331 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $32.5 Million - $36.4 Million	-525,209 Reduced 10.54%	4,455,671 $301 Million
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $61.1 Million - $68.4 Million	-976,622 Reduced 16.39%	4,980,880 $324 Million
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $139 Million - $181 Million	2,292,531 Added 62.55%	5,957,502 $373 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $37.2 Million - $41.2 Million	522,519 Added 16.63%	3,664,971 $283 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $28.7 Million - $33.5 Million	442,801 Added 16.4%	3,142,452 $223 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $61.8 Million - $75.3 Million	848,423 Added 45.83%	2,699,651 $204 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $4.93 Million - $5.79 Million	69,321 Added 3.89%	1,851,228 $133 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.21 Million - $2.63 Million	30,713 Added 1.75%	1,781,907 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,751,194	1,751,194 $124 Million

Others Institutions Holding GILD

# of Institutions

2,346

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $148B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Gilead Sciences, Inc. Transaction History